INBS submits FDA 510(k) AI response; expects clearance decision within six weeks

INTELLIGENT BIO SOLUTIONS INC.

Submitted over 1,900 pages including 23 detailed test reports and 7,800 data lines from 10,000 hours of testing.
New cybersecurity and performance data reinforce fingerprint sweat drug screening platform for U.S. market entry in 2025.
Company serves 450+ accounts in 24 countries with 18 global distribution partners.
FDA response anticipated within six weeks.
CEO calls U.S. market entry a top priority given multi-billion-dollar commercial opportunity.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.